Mechanisms Underlying the Effects of Amphetamine on Particulate PKC Activity

Synapse

Volumn 51, Issue 2, 2004, Pages 128-139

  Giambalvo, Cecilia T ^a,b  

^a Eleanor Slater Hospital   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Amphetamine; Antiporters; Phospholipase C and A2; Protein kinase C

Indexed keywords

4 BROMOPHENACYL BROMIDE; AMILORIDE; AMMONIA; AMPHETAMINE DERIVATIVE; ANTIPORTER; BENZAMIL; CALCIUM; DOPAMINE; MEPACRINE; MONENSIN; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CELL PH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM CALCIUM EXCHANGE;

AMMONIA; AMPHETAMINE; ANIMALS; CALCIUM; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; IONOPHORES; MALE; MODELS, BIOLOGICAL; MONENSIN; NEURONS; PHOSPHOLIPASES; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTOSOMES; TIME FACTORS;

EID: 0346881210     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10289     Document Type: Article

References (53)

1. Balduini W, Costa LG. 1990. Characterization of ouabain-induced phosphoinositide hydrolysis in brain slices of the neonatal rat. Neurochem Res 15:1023-1029.
2. Benuck M, Reith ME, Lajtha A. 1989. Evidence for the involvement of Na+/Ca2+ exchange in the stimulation of inositol phospholipid hydrolysis by sodium channel activation and depolarization. Eur J Pharmacol 159:187-190.
3. Berna N, Arnould T, Remacle J, Michiels C. 2001. Hypoxia-induced increase in intracellular calcium concentration in endothelial cells: role of the Na(+)-glucose cotransporter. J Cell Biochem 84:115-131.
4. Beslin A, Chantoux F, Blondeau JP, Francon J. 1995. Relationship between the thyroid hormone transport system and the Na(+)-H+ exchanger in cultured rat brain astrocytes. Endocrinology 136:5385-5390.
5. Best L, Sener A, Mathias PC, Malaisse WJ. 1984. Inhibition by mepacrine and p-bromophenacylbromide of phosphoinositide hydrolysis, glucose oxidation, calcium uptake and insulin release in rat pancreatic islets. Biochem Pharmacol 33:2657-2662.
6. Besterman JM, May Jr WS, LeVine 3rd H, Cragoe Jr EJ, Cuatrecasas P. 1985. Amiloride inhibits phorbol ester-stimulated Na+/H+ exchange and protein kinase C. An amiloride analog selectively inhibits Na+/H+ exchange. J Biol Chem 260:1155-1159.
7. Callahan BT, Cord BJ, Yuan J, McCann UD, Ricaurte GA. 2001. Inhibitors of Na(+)/H(+) and Na(+)/Ca(2+) exchange potentiate methamphetamine-induced dopamine neurotoxicity: possible role of ionic dysregulation in methamphetamine neurotoxicity. J Neurochem 77:1348-1362.
8. Canitano A, Papa M, Boscia F, Castaldo P, Sellitti S, Taglialatela M, Annunziato L. 2002. Brain distribution of the Na+/Ca2+ exchanger-encoding genes NCX1, NCX2, and NCX3 and their related proteins in the central nervous system. Ann NY Acad Sci 976:394-404.
9. Chen N, Justice JB. 2000. Differential effect of structural modification of human dopamine transporter on the inward and outward transport of dopamine. Brain Res Mol Brain Res 75:208-215.
10. de Figueiredo P, Doody A, Polizotto RS, Drecktrah D, Wood S, Banta M, Strang MS, Brown WJ. 2001. Inhibition of transferrin recycling and endosome tubulation by phospholipase A2 antagonists. J Biol Chem 276:47361-47370.
11. Exton JH. 1996. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu Rev Pharmacol Toxicol 36:481-509.
12. Giambalvo CT. 1988. Protein kinase C and dopamine release. I. Measurement by thiophosphorylation. Biochem Pharmacol 37:4001-4007.
13. Giambalvo CT. 1992a. Protein kinase C and dopamine transport. 1. Effects of amphetamine in vivo. Neuropharmacology 31:1201-1210.
14. Giambalvo CT. 1992b. Protein kinase C and dopamine transport. 2. Effects of amphetamine in vitro. Neuropharmacology 31:1211-1222.
15. Giambalvo CT. 2003. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes. Synapse 49:125-133.
16. Giambalvo CT, Price LH. 2003. Effects of fenfluramine and antidepressants on protein kinase C activity in rat cortical synaptoneurosomes. Synapse 50:212-222.
17. Hirashima Y, Farooqui AA, Mills JS, Horrocks LA. 1992. Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol. J Neurochem 59:708-714.
18. Iwata S, Hewlett GH, Gnegy ME. 1997. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse 26:281-291.
19. Jope RS, Li XH, Ormandy GC, Song L, Williams MB. 1990. Reduction of Na+ enhances phosphoinositide hydrolysis and differentiates the stimulatory and inhibitory responses to quisqualate in rat brain slices. Brain Res 536:251-256.
20. Kantor L, Gnegy ME. 1998. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-598.
21. Kantor L, Hewlett GH, Park YH, Richardson-Burns SM, Mellon MJ, Gnegy ME. 2001. Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J Pharmacol Exp Ther 297:1016-1024.
22. L'hirondel M, Cheramy A, Godeheu G, Glowinski J. 1995. Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J Neurochem 64: 1406-1409.
23. L'hirondel M, Cheramy A, Artaud F, Godeheu G, Glowinski J. 1999. Contribution of endogenously formed arachidonic acid in the presynaptic facilitatory effects of NMDA and carbachol on dopamine release in the mouse striatum. Eur J Neurosci 11:1292-1300.
24. Mancuso DJ, Jenkins CM, Gross RW. 2000. The genomic organization, complete mRNA sequence, cloning, and expression of a novel human intracellular membrane-associated calcium-independent phospholipase A(2). J Biol Chem 275:9937-9945.
25. Marin P, Hamon B, Glowinski J, Premont J. 1997. Nicotine-induced inhibition of neuronal phospholipase A2. J Pharmacol Exp Ther 280:1277-1283.
26. McPhail LC, Clayton CC, Snyderman R. 1984. A potential second messenger role for unsaturated fatty acids: activation of Ca2+-dependent protein kinase. Science 224:622-625.
27. Meng H, Pierce GN. 1991. Involvement of sodium in the protective effect of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in isolated rat ventricular wall. J Pharmacol Exp Ther 256:1094-1100.
28. Mundorf ML, Hochstetler SE, Wightman RM. 1999. Amine weak bases disrupt vesicular storage and promote exocytosis in chromaffin cells. J Neurochem 73:2397-2405.
29. Newton AC. 1997. Regulation of protein kinase C. Curr Opin Cell Biol. 9:161-167.
30. Oishi K, Raynor RL, Charp PA, Kuo JF. 1988. Regulation of protein kinase C by lysophospholipids. Potential role in signal transduction. J Biol Chem 263:6865-6871.
31. Ou-Yang Y, Kristian T, Mellergard P, Siesjo BK. 1994. The influence of pH on glutamate- and depolarization-induced increases of intracellular calcium concentration in cortical neurons in primary culture. Brain Res 646:65-72.
32. Owen PJ, Boarder MR. 1991. Influence of bradykinin on diacylglycerol and phosphatidic acid accumulation in cultured bovine adrenal chromaffin cells. J Neurochem 57:760-768.
33. 3H]phosphatidylinositol 4,5-bisphosphate hydrolysis in post-mortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J Neurochem 69:639-644.
34. Phillis JW, Ren J, O'Regan MH. 2000. Inhibition of Na(+)/H(+) exchange by 5-(N-ethyl-N-isopropyl)-amiloride reduces free fatty acid efflux from the ischemic reperfused rat cerebral cortex. Brain Res 884:155-162.
35. Pifl C, Singer EA. 1999. Ion dependence of carrier-mediated release in dopamine or norepinephrine transporter-transfected cells questions the hypothesis of facilitated exchange diffusion. Mol Pharmacol 56:1047-1054.
36. Piomelli D, Greengard P. 1991. Bidirectional control of phospholipase A2 activity by Ca2+/calmodulin-dependent protein kinase II, cAMP-dependent protein kinase, and casein kinase II. Proc Natl Acad Sci USA 88:6770-6774.
37. Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A. 2000. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci USA 97:6850-6855.
38. Scanlon JM, Brocard JB, Stout AK, Reynolds IJ. 2000. Pharmacological investigation of mitochondrial Ca(2+) transport in central neurons: studies with CGP-37157, an inhibitor of the mitochondrial Na(+)-Ca(2+) exchanger. Cell Calcium 28:317-327.
39. Schellenberg GD, Anderson L, Cragoe Jr EJ, Swanson PD. 1985. Inhibition of synaptosomal membrane Na+-Ca2+ exchange transport by amiloride and amiloride analogues. Mol Pharmacol 27:537-543.
40. Schomig E, Michael-Hepp J, Schonfeld CL. 1989. Inhibition of neuronal noradrenaline transport (uptake1) and desipramine binding by amiloride and ethylisopropylamiloride. Naunyn Schmied Arch Pharmacol 340:495-501.
41. Shinomura T, Asaoka Y, Oka M, Yoshida K, Nishizuka Y. 1991. Synergistic action of diacylglycerol and unsaturated fatty acid for protein kinase C activation: its possible implications. Proc Natl Acad Sci USA 88:5149-5153.
42. Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C. 1998. Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289-1297.
43. Smith JB, Dangelmaier C, Mauco G. 1985. Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes. Biochim Biophys Acta 835:344-351.
44. Smith JB, Dwyer SD, Smith L. 1989. Lowering extracellular pH evokes inositol polyphosphate formation and calcium mobilization. J Biol Chem 264:8723-8728.
45. Stella N, Pellerin L, Magistretti PJ. 1995. Modulation of the glutamate-evoked release of arachidonic acid from mouse cortical neurons: involvement of a pH-sensitive membrane phospholipase A2. J Neurosci 15:3307-3317.
46. Sulzer D, Maidment NT, Rayport S. 1993. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60:527-535.
47. Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A. 1995. Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102-4108.
48. Sweatt JD, Connolly TM, Cragoe EJ, Limbird LE. 1986. Evidence that Na+/ H+ exchange regulates receptor-mediated phospholipase A2 activation in human platelets. J Biol Chem 261:8667-8673.
49. Undie AS. 1999. Relationship between dopamine agonist stimulation of inositol phosphate formation and cytidine diphosphate-diacylglycerol accumulation in brain slices. Brain Res 816:286-294.
50. Wang XD, Kiang JG, Scheibel LW, Smallridge RC. 1999. Phospholipase C activation by Na+/Ca2+ exchange is essential for monensin-induced Ca2+ influx and arachidonic acid release in FRTL-5 thyroid cells. J Invest Med 47:388-396.
51. WolfWA, Schutz LJ. 1997. The serotonin 5-HT2C receptor is a prominent serotonin receptor in basal ganglia: evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis. J Neurochem 69:1449-1458.
52. Yoshihara C, Saito N, Taniyama K, Tanaka C. 1991. Differential localization of four subspecies of protein kinase C in the rat striatum and substantia nigra. J Neurosci 11:690-700.
53. Zhang L, Coffey LL, Reith ME. 1997. Regulation of the functional activity of the human dopamine transporter by protein kinase C. Biochem Pharmacol 53:677-688.